Pharmaceutical News

RSS

Cardiovascular marketing budgets hit $200 Million

Pharmaceutical companies spend more to support a cardiovascular compound's development and commercialization than other therapeutic products

12 May 2004

Restrictions by health insurers and government to control expenses may hurt the malignant melanoma drug market

Decision Resources, Inc., a research and advisory firms focusing on pharmaceutical and health care issues, finds that restrictions by health insurers and government health authorities to control expenses may hurt the malignant melanoma drug market.

12 May 2004

Bentley Pharmaceuticals lists on NYSE

The Company anticipates that its common stock will begin trading on the NYSE on Wednesday, May 12, 2004, under its current ticker symbol, “BNT.” Bentley’s common stock will continue to trade on the American Stock Exchange until that date

12 May 2004

Zocor Heart Pro to be available over the counter

Ministers have accepted the advice of the Committee on Safety of Medicines (CSM) that simvastatin 10mg (Zocor Heart Pro) could be safely sold through pharmacies to reduce the risk of a first major coronary event in people likely to be at a moderate risk of coronary heart disease (CHD).

12 May 2004

$Trial of a drug derived from the puffer fish for treatment of refractory cancer pain$

Trial of a drug derived from the puffer fish for treatment of refractory cancer pain

Investigators involved in the pivotal clinical trial of TectinTM enrolled and dosed the first of up to 150 patients that will participate in the study. It is one of the largest Canadian clinical trials to evaluate the efficacy and safety of a drug for treatment of medically refractory cancer pain, and will take place in up to 25 treatment centres across Canada.

11 May 2004

Strategy to treat obesity through molecular liposuction

Researchers at The University of Texas M. D. Anderson Cancer Center have designed a strategy to treat obesity through “molecular liposuction.” The therapy destroys blood vessels supporting fat accumulation — causing the fat to rapidly break down and disappear.

10 May 2004

More UK health professionals will be able to prescribe medicines

The proposals recommend that physiotherapists, radiographers, chiropodists and optometrists should be able to prescribe medicines, in partnership with a doctor, to help treat and manage conditions such as glaucoma, chronic back pain and the effects of multiple sclerosis, as well as providing pain relief for patients attending radiography sessions.

10 May 2004

Alternative vaccine to Dryvax for smallpox

Not everybody can safely be vaccinated against smallpox using the current FDA-approved vaccine. Scientists hope another study vaccine, now undergoing its first testing in the United States at Saint Louis University, will give a choice to people who can't be given the current vaccine, known as Dryvax®.

10 May 2004

Department of Health and Senior Services selects Medicare drug discount card provider

Health and Senior Services Commissioner Clifton R. Lacy, M.D. today announced the selection of Medco’s Preferred Prescriptions Discount Card Program to provide federal Medicare drug discount services to 81,000 beneficiaries in the state’s Pharmaceutical Assistance to the Aged and Disabled (PAAD) program.

8 May 2004

Research will test the effectiveness of new drug treatments for the cognitive deficits of schizophrenia

The National Institute of Mental Health (NIMH), of the National Institutes of Health (NIH), has awarded a four-year, $9 million contract to the University of California, Los Angeles (UCLA) and five other academic medical centers to create a network of Treatment Units for Research on Neurocognition and Schizophrenia (TURNS).

8 May 2004

Call for consumers to legally and safely import prescription drugs

In testimony before the Department of Health and Human Services Drug Importation Task Force, CVS/pharmacy Chairman, President and CEO Tom Ryan called on Congress and the Administration to quickly establish a means for consumers to legally and safely import prescription drugs.

8 May 2004

Traditional Chinese medicine contains human placenta

MHRA (Medicines) has recently become aware of a traditional Chinese medicine called Nu Bao. The product patient information leaflet lists human placenta (Placenta hominis), deer antler (Corna cervi pantotrichum) and donkey skin (Colla cori astini) as ingredients.

8 May 2004

Differing views on discount drug pricing

Medicare drug discount cards are now available for purchase. The US government estimates, the cards could save seniors as much as 25 percent of their prescription drug costs. According to a Harvard study

8 May 2004

Crime & prescription drug use in Australia

Research regarding the illicit use of prescription drugs in the Northern Territory and how this compares to other Australian states is the focus of the next presentation of Charles Darwin University’s Faculty of Education, Health and Science 2004 Seminar Program.

7 May 2004

West Nile treatment showing 100% response rate among immunocompetent patients

GenoMed, Inc. has announced that it will be limiting its treatment for West Nile virus encephalitis to immunocompetent patients only, where it has posted a 100% success rate.

7 May 2004

The world generic drug market is expected to grow 10-15% annually

Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.

6 May 2004

Study shows Chromium Picolinate and Biotin Combination significantly lowers coronary risk factors in people with Type 2 Diabetes

Results of a new double-blind, placebo-controlled, randomized clinical study show that daily nutritional supplementation with a combination of chromium picolinate and biotin (marketed as Diachromeä) significantly improved coronary risk factors in people with type 2 diabetes.

6 May 2004

FRC applauds FDA for rejecting over-the-counter pill in America's pharmacies

Citing a concern that young teenagers may not safely use the morning after pill without a doctor's guidance, the Food and Drug Administration (FDA) late today officially rejected a plan to make the pill available over-the-counter in America's pharmacies. Family Research Council President Tony Perkins released the following statement in response to the FDA's decision:

6 May 2004

Vitrase has been approved for use as an adjunct to rehydrating agents

The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.

6 May 2004

Study finds malaria drug does not affect the ability of airline crew to perform their duties

Results from a new study presented today at the 75th Annual Scientific Meeting of the Aerospace Medical Association (AsMA) in Anchorage, USA, suggest that MalaroneTM (atovaquone and proguanil hydrochloride) would not be expected to affect the ability of pilots and cabin crew to perform their duties while on an aircraft.

6 May 2004